Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease-Reference-Cited by-同舟云学术

Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease

Published:2017-11-09 Issue:19 Volume:130 Page:2121-2130
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Meinderts Sanne M.¹,Sins Joep W. R.²³,Fijnvandraat Karin²⁴,Nagelkerke Sietse Q.¹²,Geissler Judy¹,Tanck Michael W.⁵,Bruggeman Christine¹,Biemond Bart J.³,Rijneveld Anita W.⁶,Kerkhoffs Jean-Louis H.⁷,Pakdaman Sadaf⁸,Habibi Anoosha⁹,van Bruggen Robin¹,Kuijpers Taco W.¹²,Pirenne France⁸,van den Berg Timo K.¹¹⁰

Affiliation:

1. Department of Blood Cell Research, Sanquin Research, and Landsteiner Laboratory,

2. Department of Pediatric Hematology, Immunology, and Infectious Diseases, Emma Children’s Hospital, and

3. Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;

4. Department of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands;

5. Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;

6. Department of Hematology, Erasmus Medical Center, University Medical Center, Rotterdam, The Netherlands;

7. Department of Hematology, Haga Hospital, The Hague, The Netherlands;

8. Etablissement Français Du Sang Ile de France, INSERM U955, University of Paris Est-Créteil, and

9. Reference Center for Sickle Cell Disease, Hôpital Henri Mondor, Créteil, France; and

10. Department of Molecular Cell Biology, Vrije University Medical Center, Amsterdam, The Netherlands

Abstract

Key Points Variation in the Fcγ receptor gene cluster is associated with protection from RBC alloimmunization in patients with SCD. This association appears to be strongest for alloimmunization to antigens other than the immunogenic Rh or K.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/130/19/2121/1402942/blood784876.pdf

Reference72 articles.

1. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management;Yazdanbakhsh;Blood,2012

2. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience;Vidler;Br J Haematol,2015

3. Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes;Habibi;Am J Hematol,2016

4. Early occurrence of red blood cell alloimmunization in patients with sickle cell disease;Sins;Am J Hematol,2016

5. Challenges of alloimmunization in patients with haemoglobinopathies;Chou;Br J Haematol,2012

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequence variants influencing the regulation of serum IgG subclass levels;Nature Communications;2024-09-14

2. Genetic Variation and Sickle Cell Disease Severity;JAMA Network Open;2023-10-18

3. Alloimmunisation against red blood cells in sickle cell disease: transfusion challenges in high-income and low-income countries;The Lancet Haematology;2023-06

4. Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database;Annals of Hematology;2023-02-13

5. The Development and Consequences of Red Blood Cell Alloimmunization;Annual Review of Pathology: Mechanisms of Disease;2023-01-24